Succession de Rita Therrien (Metcalf)
Public foundation · Toronto, Ontario · BN 765410725RR0001 · Foundations
Source: T3010 return, FPE 2024-12-31. Split of total expenditures ($59,197) as filed with the CRA.
Succession de Rita Therrien (Metcalf) is a public foundation based in Toronto, Ontario, classified by the CRA under foundations. In its fiscal year ending December 31, 2024, it reported $50K in revenue and $59K in expenditures. Spending exceeded revenue that year — the gap came out of reserves.
Compared with 3,025 grantmaking charities of similar size, its share of spending on mission — charitable programs plus grants to other charities — ranked above 29% of peers.
As a grantmaker, it reported gifts to 1 qualified donee totalling $46K in 2024, the largest being $46K to Santropol roulant inc./ Santropol On Wheels Inc.. Revenue has grown substantially over its filings on record here, from $32K in 2020 to $50K in 2024. Its filed list of directors and trustees shows 1 name.
In its own words
To distribute the net revenues of the charitable trust to santropol roulant
Ongoing-program description from its T3010 filing, verbatim.
The ledger, 2020–2024
| Year | Revenue | Spending | Programs | Fundraising | Gifts out | Net assets |
|---|---|---|---|---|---|---|
| 2024 | $50K | $59K | — | — | $46K | $696K |
| 2023 | $46K | $36K | — | — | $24K | $686K |
| 2022 | $49K | $39K | — | — | $26K | $632K |
| 2021 | $51K | $38K | — | — | $24K | $738K |
| 2020 | $32K | $35K | — | — | $23K | $726K |
Revenue printed in red where the year ran a deficit. Fiscal years by period end.
Money between charities, 2024
Granted $46K to 1 qualified donee:
As reported on the donors’ own T3010 qualified-donee schedules.
Directors & trustees (2024)
Scotiatrust (trustee).
As listed on its 2024 return.
Check the source
Every figure on this page is from Succession de Rita Therrien (Metcalf)’s own T3010 filings, published by the Canada Revenue Agency. Verify against the CRA’s charities listing (search BN 765410725RR0001), or read how we compute the receipt.